Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
Stopped early
Conditions studied: Familial Adenomatous Polyposis
In brief
This study reviews post study clinical endoscopy reports in follow up to patients who participated in MAY2016-07-01 with weekly erlotinib for familial adenomatous polyposis. Reviewing follow up medical records may help researchers examine the extent of rapid progression of familiar adenomatous polyposis disease burden after discontinuation of weekly erlotinib.
Key facts
- Study ID
- NCT04674228
- Run by
- National Cancer Institute (NCI)
- People needed
- 42
- Starts
- 2021-05-07
- Expected to finish
- 2022-05-17
- Last updated by the study team
- 2026-06-11
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- MAY2016-07-01 study participants for whom medical records are available and accessible
You may not qualify if…
- MAY2016-07-01 study participants who have opted out of medical records reviews or for whom consent for medical record review cannot be confirmed/documented
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
- M D Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.